Thursday, 28 March 2024


MGI brings innovative genetic sequencer, MGISEQ-T7

29 October 2018 | News

The MGI proprietary technology used in T7 delivers higher accuracy and improves efficiency through upgrades to the flow cell, fluid, and biochemical and optical system.

MGI, a subsidiary of BGI Group, introduced its newest model of genetic sequencer, MGISEQ-T7, which vastly improves speed, throughput and flexibility, at the 13th International Conference on Genomics (ICG-13) in Shenzhen.

The most powerful MGI sequencer to date, MGISEQ-T7 is built with innovative quadruple flow-cell staging that allows simultaneous but independent operation of 1 to 4 flow cells in a single run.

The MGI proprietary technology used in T7 delivers higher accuracy and improves efficiency through upgrades to the flow cell, fluid, and biochemical and optical system. A supercomputer for the life science industry, MGISEQ-T7 takes the production capacity of the sequencer to a new level with the daily output of data up to 6Tb.

"Now customers have complete flexibility for a wide range of sequencing all in one machine," said MGI CEO Feng Mu.

"MGI is the first company that can achieve affordable and essentially error-free genome sequencing," said Dr. George Church, Professor of Genetics, and Health Sciences and Technology of Harvard and MIT.

The ultra-fast, ultra-high-throughput MGISEQ-T7 can complete WGS for up to 60 human genomes in a single day, breaking barriers for what a next-generation sequencer can do. MGISEQ-T7 accelerates the development of nationwide genomics projects since a T7 can complete the sequencing of 10,000 genomes within a year.

BGI Group President Jian Wang said such research will benefit human beings everywhere. "The mission of MGI is to help people live better and healthier lives."

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account